Ceritinib
Ceritinib Brand Name– Zykadia What is Ceritinib Ceritinib is an oral kinase inhibitor, primarily targeting anaplastic lymphoma kinase (ALK) but also insulin-like growth factor 1 (IFG-1) and ROS1. It has demonstrated efficacy in the first-line metastatic non-small cell lung cancer (NSCLC) setting as well as after failure of crizotinib; unlike some other kinase inhibitors, ceritinib …
